Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial. 1987

S Gundersen, and S Monfardini, and G Renard, and M Van Glabbeke, and H Pinedo
Det Norske Radiumhospital, Oslo, Norway.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009621 Nogalamycin An anthrocycline from a Streptomyces nogalater variant. It is a cytolytic antineoplastic that inhibits DNA-dependent RNA synthesis by binding to DNA. U-15167,U 15167,U15167
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S Gundersen, and S Monfardini, and G Renard, and M Van Glabbeke, and H Pinedo
August 1983, European journal of cancer & clinical oncology,
S Gundersen, and S Monfardini, and G Renard, and M Van Glabbeke, and H Pinedo
September 1988, Investigational new drugs,
S Gundersen, and S Monfardini, and G Renard, and M Van Glabbeke, and H Pinedo
August 1982, European journal of cancer & clinical oncology,
S Gundersen, and S Monfardini, and G Renard, and M Van Glabbeke, and H Pinedo
December 1982, European journal of cancer & clinical oncology,
S Gundersen, and S Monfardini, and G Renard, and M Van Glabbeke, and H Pinedo
February 1987, Cancer treatment reports,
S Gundersen, and S Monfardini, and G Renard, and M Van Glabbeke, and H Pinedo
April 1989, European journal of cancer & clinical oncology,
S Gundersen, and S Monfardini, and G Renard, and M Van Glabbeke, and H Pinedo
January 1996, European journal of cancer (Oxford, England : 1990),
S Gundersen, and S Monfardini, and G Renard, and M Van Glabbeke, and H Pinedo
February 1987, European journal of cancer & clinical oncology,
S Gundersen, and S Monfardini, and G Renard, and M Van Glabbeke, and H Pinedo
February 1983, European journal of cancer & clinical oncology,
S Gundersen, and S Monfardini, and G Renard, and M Van Glabbeke, and H Pinedo
September 1987, Cancer treatment reports,
Copied contents to your clipboard!